Serum Magnesium after Kidney Transplantation: A Systematic Review
AbstractMagnesium (Mg) status has recently drawn close attention in chronic kidney disease and in kidney transplant recipients. This review aims to evaluate the body of evidence linking hypomagnesemia to clinical consequences in these specific populations. After a brief summary of the main mechanisms involved in Mg regulation and of Mg status in end-stage renal disease, the review focuses on the relationship between hypomagnesemia and cardiovascular risk in kidney transplant recipients. A body of evidence in recent studies points to a negative impact of hypomagnesemia on post-transplant diabetes mellitus (PTDM) and cardiovascular risk, which currently represent the main threat for morbidity and mortality in kidney transplantation. Deleterious biological mechanisms induced by hypomagnesemia are also discussed. While data analysis enables us to conclude that hypomagnesemia is linked to the development of PTDM, studies prospectively evaluating the impact of hypomagnesemia correction after kidney transplantation are still lacking and needed. View Full-Text
Share & Cite This Article
Garnier, A.-S.; Duveau, A.; Planchais, M.; Subra, J.-F.; Sayegh, J.; Augusto, J.-F. Serum Magnesium after Kidney Transplantation: A Systematic Review. Nutrients 2018, 10, 729.
Garnier A-S, Duveau A, Planchais M, Subra J-F, Sayegh J, Augusto J-F. Serum Magnesium after Kidney Transplantation: A Systematic Review. Nutrients. 2018; 10(6):729.Chicago/Turabian Style
Garnier, Anne-Sophie; Duveau, Agnès; Planchais, Martin; Subra, Jean-François; Sayegh, Johnny; Augusto, Jean-François. 2018. "Serum Magnesium after Kidney Transplantation: A Systematic Review." Nutrients 10, no. 6: 729.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.